Prodrugs of succinic acid for increasing atp production
MA39856AUndetermined Publication Date: 2017-02-15NEUROVIVE PHARMA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA39856
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-04-08
- Filing Date
- 2015-04-08
- Publication Date
- 2017-02-15
Abstract
The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing atp-production in mitochondria. The main part of atp produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the kreb's cycle. Not all kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial atp-output.
Need to check novelty before this filing date? Find Prior Art